ARTICLE | Company News
TopoTarget, BioImage cancer deal
December 22, 2005 2:50 AM UTC
TopoTarget (CSE:TOPO) acquired from Bio Image (Copenhagen, Denmark) a preclinical cancer program that includes about 100 diphenyl ox-indole-2-one compounds, which act via the mTOR signaling pathway. T...